-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Lyell Immunopharma with Market Outperform Rating, Announces Price Target of $34

Benzinga·03/09/2026 12:55:44
Listen to the news
Citizens analyst Reni J. Benjamin initiates coverage on Lyell Immunopharma (NASDAQ:LYEL) with a Market Outperform rating and announces Price Target of $34.